Biological Safety Testing Market to Reach $11.34B by 2030
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Is The Market Size Of The Biological Safety Testing Products And Services Market Expected To Change From 2026 To 2030?
The biological safety testing products and services market has experienced significant growth in recent years. It is forecast to increase from $6.12 billion in 2025 to $6.93 billion by 2026, registering a compound annual growth rate (CAGR) of 13.3%. Historically, this growth has been fueled by factors such as the rising production of vaccines and biologics, an expansion in pharmaceutical manufacturing capacity, heightened regulatory scrutiny concerning product safety, the broader adoption of cell and gene therapies, and an increase in clinical research activities.
The biological safety testing products and services market size is anticipated to experience substantial growth in the upcoming years. It is projected to expand to $11.34 billion by 2030, achieving a compound annual growth rate (CAGR) of 13.1%. This expansion during the forecast period is fueled by increasing demand for advanced biologics safety assays, rising investments in automated testing platforms, the ongoing expansion of gene and cell therapy pipelines, a growing requirement for faster release testing, and an increasing emphasis on mitigating contamination risks. Noteworthy trends for the forecast period include the increasing adoption of rapid microbial detection methods, a rising demand for automated sterility testing systems, the growing utilization of PCR-based safety testing, an expansion of outsourced biological testing services, and an enhanced focus on regulatory-compliant testing solutions.
Access Your Free Sample Report For In-Depth Market Analysis:
What Leading Drivers Are Supporting The Biological Safety Testing Products And Services Market Expansion?
The escalating demand for gene therapies is projected to fuel the expansion of the biological safety testing products and services market moving forward. Gene therapy, a medical strategy, utilizes genes to manage or avert diseases by substituting, altering, or supplementing deficient genes. Augmented investments and research focused on gene mutation, combined with supportive regulatory environments, are further hastening innovation and expanding the scope of gene therapeutic applications. Biological safety testing products and services play a vital role in gene therapy by ensuring that viral vectors and genetic materials are free from contaminants and safe for use. An illustration of this trend is found in a document published in January 2024 by the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, which reported that in quarter four, 2023, the number of gene therapies in Phase III clinical trials increased by 10%, marking the first quarterly surge of this nature since quarter three, 2022. This increasing need for gene therapies, therefore, serves as a significant impetus for the biological safety testing products and services market.
Which Segment Categories Are Included In The Biological Safety Testing Products And Services Market Segment Analysis?
The biological safety testing products and services market covered in this report is segmented –
1) By Product: Reagents And Kits, Instruments, Services
2) By Test Type: Endotoxin Tests, Sterility Tests, Cell Line Authentication And Characterization Tests, Bioburden Tests, Adventitious Agent Detection Tests, Residual Host Contamination Detection Tests, Other Test Types
3) By Application: Vaccines And Therapeutics, Blood And Blood-Based Products, Gene Therapy, Tissue And Tissue-based Products, Stem Cell
Subsegments:
1) By Reagents And Kits: Endotoxin Testing Kits, Mycoplasma Detection Kits, Sterility Testing Kits, Microbial Detection Reagents, Cell Culture Media Reagents
2) By Instruments: PCR Instruments, Microplate Readers, Bioluminescence Detection Systems, Automated Cell Culture Systems, ELISA Readers
3) By Services: Microbial Testing Services, Biocompatibility Testing Services, Endotoxin Testing Services, Environmental Monitoring Services, Consulting And Validation Services
What Emerging Trends Are Seen In The Biological Safety Testing Products And Services Market?
Leading companies operating in the biological safety testing products and services market are developing swift, animal-free bacterial endotoxin testing methods to enhance patient safety and accelerate drug development. This innovative approach aims to shorten testing periods and improve reliability, all without incorporating animal-based products. For example, in January 2024, Charles River Laboratories International, a US-based pharmaceutical and biotechnology company, unveiled the Endosafe Trillium cartridge. This product leverages recombinant technology to detect and quantify endotoxins, entirely free from animal-derived materials. It stands as the first rapid animal-free bacterial endotoxin test offering a quicker turnaround and eliminating the need for animal-derived reagents, thereby boosting sustainability and ethical testing practices. The aim of this product is to provide prompt, accurate results while decreasing reliance on the conventional Limulus amebocyte lysate (LAL) sourced from horseshoe crabs.
Who Are The Active Companies Shaping The Biological Safety Testing Products And Services Market?
Major companies operating in the biological safety testing products and services market are Merck KGaA, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, SGS Société Générale de Surveillance SA, Eurofins Scientific, Agilent Technologies Inc., Lonza Group AG, WuXi AppTec Co. Ltd., Charles River Laboratories Inc., BioMérieux SA, Almac Group, Samsung Biologics Co. Ltd., Maravai LifeSciences Holdings Inc., Genscript Biotech Corp, Wako Pure Chemical Industries Ltd., Associates of Cape Cod Inc., InvivoGen S.A.S., Microcoat Biotechnologie GmbH, BSL BIOSERVICE Scientific Laboratories Munich GmbH, Redberry, PathoQuest
Get The Full Biological Safety Testing Products And Services Market Report:
Which Region Has The Greatest Market Share In The Biological Safety Testing Products And Services Market?
North America was the largest region in the biological safety testing products and services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biological safety testing products and services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Biological Safety Testing Products And Services Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Biological Safety Testing Products And Services Market 2026, By The Business Research Company
Bioanalytical Testing Services Market Report 2026
Food Pathogen Safety Testing Equipment And Supplies Market Report 2026
Agriculture Biologicals Testing Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
